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An extracellular matrix (ECM) is a complex net-
work of adhesive proteins and proteoglycans, which 
regulates morphology, adhesion, proliferation, migra-
tion and differentiation of mammalian cells. It is well 
known that tumor cells interact with ECM components, 
such as laminin (LN), fibronectin (FN), and collagen 
type I (COL-I), via certain adhesion molecules such as 
integrins [1, 2]. Integrins are heterodimers consisting 
of α and β subunits and over 20 types of heterodimers 
have been identified to date [3]. In addition, ECM-
integrin interaction stimulates signal transduction 
pathways that regulate a number of cellular processes 
in cancer growth, including cell cycle transition and 
protection from apoptosis [4]. Many investigators have 
reported that ECM consists of collagens, VN, LN, and 
ligands for integrins [5–7]. Moreover, integrins attach 
to ECM ligands and induce the stimulation of intercel-
lular signals suggesting that integrins are, at least in 
part, involved in the prevention of cell death [8]. 
Taxol (paclitaxel) and camptothecin (also known as 
irinotecan) are plant-derived antitumor agents. These 
drugs have been widely used for treatment of ovarian, 
breast, stomach, and non-small cell lung cancers. 
The mechanism of the antitumor effect by taxol (pa-
clitaxel) is believed to be antimitotics, specifically the 
promotion of the irreversible assembly of tubulin into 
microtubules [9]. Camptothecin has also been devel-
oped as a chemotherapeutic agent and has significant 
antitumor activity by inhibiting DNA topoisomerase I 
[10, 11]. Although both drugs administered possess 
potent antitumor activity, recent reports have shown 
that treatment of these drugs to patients with malig-
nancies has resulted in multidrug resistance [12]. 
Of the mechanisms of drug-resistance, two major 
mechanisms have been predicted. One is believed to be 
an over-expression of multidrug resistance 1 (MDR1), 
which is a gene encoding P-glycoprotein [13, 14]. This 
membrane-bounded protein acts as an efflux pump 
resulting in the decrease of the drug concentration 
within the cells [13, 14]. The other mechanism is known 
to be tubulin mutations resulting in alterations of either 
the assembly or stability of microtubules [15, 16]. In this 
respect, Damiano et al. have reported drug resistance 
to antitumor agents upon cell adhesion to extracellular 
matrix proteins [17]. Their report suggests that cell-
cell adhesion or some morphological changes may be 
involved in drug resistance of cancer cells.
In general, the expression of adhesion molecules 
on the cell surface is believed to mediate the cell-ECM 
interaction and signal transduction regulating the cell 
survival process [18]. However, there is still limited data 
concerning the relationship between drug resistance and 
the cell-ECM interaction.
This paper describes the effect of anticancer drugs 
on tumor cell-cell adhesion and the effect of ECM com-
ponents on drug resistance of tumor cells. Our results 
are expected to facilitate research on the study of the 
acquisition of drug resistance and would provide new 
insight into the molecular mechanism of drug resistance 
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when exposed to anticancer drugs such as taxol (pacli-
taxel) and camptothecin.
MATERIALS AND METHODS
Chemicals. Camptothecin, paclitaxel (taxol) 
and XTT sodium salt were purchased from Sigma-
Aldrich Co. (St. Louis, MO, USA). All other chemicals 
were of the highest grade commercially available. 
Cell culture. MCF-7 cells were obtained from the 
Japan Health Sciences Foundation (Tokyo, Japan). 
Caco-2 and NCI-H292 cell lines were purchased 
from American Type Culture Collections (Manassas, 
VA, USA). MCF-7 cells were maintained in a minimum 
essential medium (MEM) (Invitrogen, Carlsbad, CA, 
USA) supplemented with 0.15% NaHCO3, 10% fetal 
bovine serum (FBS, Invitrogen, Carlsbad, CA, USA), 
1 mM pyruvic acid sodium salt (MP Biomedicals, Inc., 
Solon, OH, USA), 0.001% insulin, 100 units/mL peni-
cillin G and 100 μg/mL streptomycin. NCI-H292 and 
Caco-2 were maintained in RPMI 1640 (Sigma-
Aldrich Co., St. Louis, MO, USA) containing 10% FBS 
and were grown at 37 °C in the presence of 5% CO2. 
The cells were cultured in a humidified 5% CO2 incuba-
tor at 37 °C, and were sub-cultured twice at week. The 
medium was regularly changed three times a week. 
Cell culture on ECMs. 96-well plates (Corning Inc, 
NY, USA) were coated with 10 μg/mL COL-I (KOKEN, 
Tokyo, Japan), VN (KOKEN, Tokyo, Japan), Matrigel 
(BD Bioscience, San Jose, CA, USA), or FN (Sigma-
Aldrich, St. Louis, MO, USA) dissolved in phosphate-
buffered saline (PBS) and allowed to air dry overnight 
under UV irradiation. 10 μg/mL heat-denatured BSA 
(Fraction V, Sigma-Aldrich, St. Louis, MO, USA) in PBS 
was added into each culture well for 1 h at 37 °C to block 
the nonspecific binding site. Cells (2 × 103 cells/mL) 
were cultured on ECM pre-coated plates and incubated 
at 37 °C. After 24 h, camptothecin or taxol (paclitaxel) 
was added to the plates at concentrations of 10 nM, 
100 nM, 1 μM or 10 μM and incubated for 72 h at 37 °C. 
The cell cultures were washed three times with PBS, and 
the cytotoxicity was assessed by XTT assay.
Three-dimensional cell culture. The method for 
three-dimensional culture was described previously 
[19]. Briefly, cells were cultured with Matrigel, and 
a collagen gel solution (0.5 mL) consisting of eight 
bed volumes of COL-I solution (KOKEN, Tokyo, Ja-
pan) concentrated by MEM and reconstituted buffer 
(0.05 M NaOH, 200 mM HEPES, and 260 mM NaHCO3) 
were added to each well (50 μL/well) and incubated 
for 60 min at 37 °C. Cell suspension (2 × 103 cells/mL) 
containing 10% FBS was added to the wells and cul-
tured. After 24 h, camptothecin or paclitaxel (taxol) 
was added to the wells and incubated for 72 h at 37 °C. 
The cells were randomly selected from each well and 
photographs were taken under a phase-contrast mi-
croscope [x 400].
Preparation of artificially aggregated cells. 
An MCF-7 cell suspension (2 x 103 cells/20 μL) was 
seeded on the lids of 10-cm diameter dishes (BD 
Biosciences, San Jose, CA, USA). To allow cell-cell 
aggregation, the culture was incubated for 24 h. After 
24 h incubation, 20 μL of a medium containing one 
cluster of cells was supplemented with 80 μL of MEM 
containing camptothecin or taxol (paclitaxel), and 
subsequently incubated for 72 h. 
Assessment of the cytotoxicity of anticancer 
drugs. The effects of paclitaxel and camptothecin on 
cell growth were assessed by XTT assay. 50 μL of XTT 
solution containing phenazine methyl sulfate and XTT 
was added to a 96-well culture plate and measured at 
490 nm. The assay was repeated at least three times 
to confirm the results.
Measurement of cytotoxicity in spheroid tumor 
cells. Cytotoxicity of taxol (paclitaxel) and camptothe cin 
toward spheroid tumor cells was determined by measur-
ing the area occupied by spheroid cells. Three-dimen-
sional cultured cells or aggregated cells were seeded 
onto culture plates and treated with taxol (paclitaxel) or 
camptotethcin as indicated in Tables 1, 2. After 72 h, the 
spheroid cell size was measured with a computer as-
sisted image analyzer (Image Hyper II, Osaka, Japan). 
Cell growth was expressed as the percentage of growth 
of cells in the absence of taxol (paclitaxel) or camptoth-
ecin. Fifty percent inhibition of cell proliferation (IC50) was 
calculated from the concentration-response curve.
Table 1. Effects of several components of ECM on cancer cell survival 
upon treatment with anticancer drugs
Survival (%)
BSA FN VN COL-I Matrigel
Caco-2
Taxol 19.2 ± 0.5
24.5 ± 
5.3
22.5 ± 
5.1
49.7 ± 
3.1*
30.7 ± 
4.2*
Сampto-
thecin
4.7 ± 0.4 4.6 ± 0.5 4.1 ± 0.5 84.0 ± 
17.1*
55.9 ± 
1.2*
MCF-7
Taxol 53.9 ± 7.7
45.3 ± 
1.0
36.3 ± 
0.8
82.0 ± 
2.4*
87.3 ± 
1.0*
Campto-
thecin
64.3 ± 
5.0
42.8 ± 
0.6
48.4 ± 
5.1
114.2 ± 
1.9*
100.6 ± 
1.8*
NCI-H292
Taxol 31.9 ± 0.8
29.1 ± 
1.8
34.5 ± 
0.5
36.1 ± 
1.2*
124.1 ± 
5.7*
Campto-
thecin
35.4 ± 
1.1
37.0 ± 
0.2
34.1 ± 
2.0
50.1 ± 
0.7*
69.6 ± 
4.8*
Notes: Caco-2, MCF-7, and NCI-H292 cells were seeded on VN-, FN-, COL-I-, 
matrigel-, or BSA-coated cultured plates, and incubated at 37 °C. After 24 h 
of incubation, the cultures were supplemented with 10 µM anticancer drugs 
and cultured for 72 h. Cell survival was measured by XTT assay. Data are 
expressed as mean ± S.E. (*P < 0.05 vs BSA). BSA, bovine serum albmin; 
FN, fibronectin; VN, vitronectine; COL-I, collagen type I.
Table 2. Effects of anticancer drugs on spheroidal cells
IC50 (µM)
Normal Culture Spheroidal Culture
MCF-7 Taxol (Paclitaxel) 1.62 ± 0.32 3.91 ± 0.60*Camptothecin 3.13 ± 1.24 27.06 ± 3.56*
Notes: Cell suspension or spheroidal cells of MCF-7 cells were seeded into 
the culture plate and supplemented with various concentrations of taxol 
(paclitaxel) or camptothecin. After 72 h incubation, the area of spheroidal 
cells was measured with an image analyzer. The IC50 values of cell proliferation 
were calculated from the dose-response curve. Data are expressed as mean ± 
S.E. of 3–6 independent experiments (*P < 0.05).
Morphological observation. MCF-7 cells were 
cultured on ECM-coated plates. After 24 h, morpho-
logical changes of the cells were observed with a phase 
contrast microscope (Olympus, Tokyo, Japan) after the 
cells were fixed with 2.5% glutaraldehyde in PBS. 
Effect of anticancer drugs on monolayer cells 
co-cultured with MCF-7 colonies. Using a trans-well 
chamber (Costar, Cambridge, MA, USA), MCF-7 cells 
(4 x 104 cells/80 μL) were cultured and added to the 
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COL-I-, Matrigel-, or BSA-coated plates and the cells 
were maintained for 2 to 3 days at 37 °C. 10 μM of camp-
tothecin was added to a lower well and incubated for 72 h. 
Cell growth inhibition was determined by XTT assay. 
Immunofluorescence. The MCF-7 cells were 
cultured on the COL-l- or Matrigel-coated culture 
slides (BD Biosciences, San Jose, CA, USA) with or 
without paclitaxel for 24 h. The cells were fixed with 4% 
paraformaldehyde in PBS for 20 min and subsequently 
soaked in phosphate buffered saline (PBS) for 10 min. 
They were then permeabilized with 0.2% Triton X-100 in 
PBS for 10 min and blocked by PBS containing 3% BSA 
for 30 min at room temperature. Immunostaining was 
performed using monoclonal anti-β-tubulin clone TUB 
2.1 antibody (1 : 200; Sigma-Aldrich, St. Louis, MO, 
USA). Fluoroscein isothiocyanate (FITC)-conjugated 
anti-β-tubulin monoclonal antibody (Sigma-Aldrich Co., 
St. Louis, MO, USA) was used for this experiment. Initial 
incubation was performed using PBS containing 3% 
BSA for 2 h at room temperature. Anti-mouse IgG an-
tibody conjugated to fluoroscein isothiocyanate (FITC) 
(1 : 100; Sigma-Aldrich, St. Louis, MO, USA) was used 
for secondary detection and DAPI (1 : 5,000; Invitrogen, 
Carlsbad, CA, USA) was used for nuclear staining. The 
stained cells were examined using a laser scanning 
confocal microscope (KEYENCE, Osaka, Japan).
Effects of IL-6 and -8 on the cytotoxicity of anti-
cancer drugs. MCF-7 cells (2 × 103 cells/mL) were cul-
tured in on 96-well plates and incubated at 37 °C. After 
24 h incubation, camptothecin (10 μM) with or without 
recombinant human IL-6 and IL-8 (Peprotech, London, 
UK) were added at the dose of 1 and 10 ng/mL to the 
wells and subsequently incubated for 72 h at 37 °C, then 
the cell viability was assessed by the XTT assay. 
Statistical analysis. Statistical analysis was 
performed with the Bonferroni-Dunn procedure after 
ANOVA or the Mann-Whitney test. Data are expressed 
as the mean ± S.E. of each experiment (P < 0.05).
RESULTS AND DISCUSSION
It is known that cancer cells adhere to ECM via 
integrins, which contribute to the acquisition of drug 
resistance. To elucidate the role of cell adhesion in 
the process of acquisition of drug resistance toward 
antineoplastic agents, we studied the effect of taxol 
(paclitaxel) and camptothecin on three human cancer 
cell lines, human colon carcinoma cells (Caco-2), 
mammary breast cancer (MCF-7), and lung carcinoma 
cells (NCI-H292). These cell lines have been widely 
used for examining the effects of anticancer drugs. 
Cells were cultured on BSA-coated culture plates for 
24 h to allow cell adhesion, and incubated with a me-
dium containing taxol (paclitaxel) or camptothecin at 
different concentrations for 72 h. As shown on Fig. 1, 
the cell survivals were decreased in a concentration-
dependent manner. However, we did not observe any 
significant differences in cell survival among these cell 
lines. Cell growth was significantly inhibited when cells 
were treated with camptothecin or taxol (paclitaxel). 
The effects of ECMs (FN, VN, COL-I, and Matrigel) 
on cell growth inhibition by taxol (paclitaxel) and camp-
tothecin were subsequently investigated. Table 1 shows 
the survival rates of Caco-2, MCF-7 and NCI-H292 cells 
cultured with various ECMs. As shown in Table 1, survival 
rates were higher when cells were cultured on COL-I- 
or Matrigel-coated plates compared with BSA. After 
treatment with camptothecin, MCF-7 cells grown on 
COL-I- and Matrigel-coated plates showed a marked 
increase of survival rate to114.2% and 100.6%, respec-
tively. Similar results have been observed when adding 
paclitaxel (taxol) to MCF-7. Thus, we found that COL-I 
and Matrigel promoted cell survival despite of anti-
cancer drug treatment. However, we did not observe 
any significant changes of survival rates in all cell lines 
cultivated on FN- or VN-coated plates. 
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Fig. 1. Concentration-dependent inhibitory effects of anticancer 
drugs on cell proliferation. Caco-2 (a), MCF-7 (b), and NCI-H292 
(c) cells were cultured on bovine serum albumin (BSA)-coated 
plates, and incubated at 37 °C for 24 h. After 24 h, camptothecin 
( ) or taxol (paclitaxel) ( ) was added to the culture medium at 
various concentrations, and then cultured for 72 h. The inhibitory 
effect was measured by XTT assay. Cell survival rate is expressed 
as % of non-drug-treated cells
Cell-to-ECM adhesion is a crucial event in multi-cel-
lular organisms for the modulation of cellular processes 
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such as growth and differentiation [20]. Particularly, 
regulation of anchorage-dependent processes is im-
portant for cell-ECM interaction [21]. Generally, the 
proliferation of many anchorage-dependent cell types is 
restricted to ECM-adhering cells [22, 23]. Lohi et al. [24] 
reported that collagen IV expression is increased in the 
tumor microenvironment. Except for FN and collagen, 
basement membrane ECM (Engelbreth-Holm-Swarm) 
suppressed apoptosis of CID-9 mammary epithelial 
cells and was induced by anti-integrin β1 antibodies 
[25]. Cultured human endothelial cells retained viability 
by FN and VN treatment, and endothelial cell survival 
on VN was assumed to be mediated by integrin αvβ3 
[26]. On the other hand, Chinese hamster ovary (CHO) 
cells can survive on FN but not on VN via integrin α5β1 
[27]. Thus, the role of cell-to-ECM interaction in sur-
vival depends on the cell line. These findings together 
with our previous results suggest that the cell-to-ECM 
interaction influences the survival of cells. 
In the present study, the decrease of susceptibility 
to taxol (paclitaxel) and camptothecin was observed 
in the cells cultured on COL-I- and Matrigel-coated 
dishes (see Table 1). Since integrin β1 is an inhibi-
tor of apoptosis, our results suggested that integrin 
β1 participated in the acquisition of resistance to taxol 
(paclitaxel) and camptothecin, and that these drugs 
are unable to affect cell growth when cells are cultured 
on COL-I and Matrigel. 
Based on the results presented in Table 1, we sub-
sequently investigated the morphological influence 
of ECMs (BSA, FN-, VN-, COL-I, and Matrigel) on 
MCF-7 cells. As shown on Fig. 2, MCF-7 cells were cul-
tured on BSA (Fig. 2, a), FN (Fig. 2, b), and VN (Fig. 2, c) 
and formed a monolayer. Interestingly, MCF-7 cells 
when cultured on COL-I and Matrigel-coated dishes 
exhibited colony formation (Figs. 2, d and 2, e). How-
ever, colony formation was not observed for Caco-2 and 
NCI-H292 cells (data not shown). Previously, it was 
shown by Hirtenlehne et al. [28] that MCF-7 cells are 
able to form clusters when cultured on LN-coated plates. 
In addition, Kobayashi et al. [29] and Hoffman et al. [30] 
have reported that drug resistance has occurred when 
spheroid cells were cultured under in-vivo-like condition. 
Furthermore, Sakata et al. [31] reported that spheroid 
formation appeared to be more sensitive to drug resis-
tance when compared with monolayer cultures. Based 
on their findings, the effect of morphological changes 
on drug resistance was proposed and further studied. 
We found that there was a correlation between morpho-
logical changes (spheroid formation) and decreased 
survival of cultured cells upon anticancer drug treatment 
(see Fig. 2, Table 1). Duan et al. [32] have shown that a 
three-dimensional culturing of MCF-7 cells could induce 
doxorubicin resistance. These authors suggested that 
cell-cell contacts could play a key role in the develop-
ment of doxorubicin resistance. Larjava [33] have found 
that the interaction between ECM and integrin resulted 
in cytoskeletal rearrangements. Taking published results 
and our results into consideration, it could be assumed 
that the acquisition of drug resistance may be involved 
in morphological changes when cells are cultured with 
ECM components.
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Fig. 2. Morphological changes of MCF-7  cells cultured on 
various types of ECMs. MCF-7 cells formed an island-shaped 
monolayer on BSA (a), FN (b) and VN (c), whereas cultured on 
COL-I (d) and Matrigel (e) exhibited colony formation. Other ex-
perimental conditions and details are described in the Materials 
and Me thods section. a–e, x 400
To elucidate whether the morphological chan-
ges could affect cell survival, artificially aggregated 
MCF-7 cells (spheroid cells) were seeded and compared 
with cells grown in monolayers. The results are presented 
in Table 2. When MCF-7 cells were grown in monolayer, 
the IC50 values for taxol (paclitaxel) and camptothecin 
was 1.62 ± 0.32 μM and 3.13 ± 1.24 μM, respectively. 
On the other hand, when cells were grown as spheroid 
culture, the IC50 values for taxol (paclitaxel) or camp-
tothecin increased by 2.4 times and 8.7 times, respec-
tively. These findings indicated that drug resistance of 
spheroid-cultured cells was more significant than that 
of monolayer-cultured cells. Also, we could suggest that 
not only the cell-integrin-ECM interactions, but also cell-
cell interactions could be involved in acquisition of drug 
resistance against some drugs by cancer cells.
It has been demonstrated that paclitaxel promotes 
the assembly of microtubules from tubulin dimers and 
stabilizes microtubules by preventing depolymerization 
[34]. Such stability results in the inhibition of the normal 
dynamic reorganization of the microtubule network re-
quired for vital interphase and mitotic intracellular func-
tions [35]. On the basis of these findings, we decided to 
investigate the effect of paclitaxel, COL-I, and Matrigel 
on the paclitaxel-induced tubulin polymerization. The 
immunofluorescent staining of the microtubules’ orga-
nization in MCF-7 cells cultured on BSA-, COL-I-, and 
Matrigel-coated plates without paclitaxel treatment is 
shown on Fig. 3 (a–c). As de monstrated on Fig. 3, d, the 
thick circumferential bundles of microtubules around 
the periphery of the cell and chromatin condensation 
was observed for MCF-7 cells on BSA plates with 1 μM 
paclitaxel. However, we did not observe similar effect of 
paclitaxel on MCF-7 cells cultured on COL-I- and Matri-
gel-coated plates (Figs. 3, e and 3, f). Ahmed et al. [36] 
have reported previously that loss of the ECM protein 
TGF-β1 (transforming growth factor beta 1) is sufficient 
to induce specific resistance to paclitaxel and mitotic 
spindle abnormalities in ovarian cancer cells. Our re-
sults suggest that COL-I and Matrigel induce paclitaxel 
resistance in MCF-7 breast carcinoma cells at the level 
of chromatin condensation and microtubules. 
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Fig. 3. COL-I and Matrigel induces paclitaxel resistance at the 
level of chromatin condensation and microtubules. Immuno-
fluorescence micrograph exhibits the microtubule organization 
in a MCF-7 on BSA, COL-I, and Matrigel before the addition of 
paclitaxel (a–c). MCF-7 cells on BSA (d), COL-I (e) and Matrigel 
(f) were treated with 1 μM paclitaxel for 24 h. Other experimental 
conditions and details are described in Materials and Methods 
section. Green, tubulin; blue, DNA. Scale bar, 50 μm
Using a trans-well chamber, next we examined 
whether monolayer cells could acquire drug resistance. 
When MCF-7 cells were cultured on Matrigel- and 
COL-I-coated upper-wells, the cellular shape was 
spheroid. However, MCF-7 cells formed a monolayer on 
non-coated wells, but any apparent colony formation was 
observed (data not shown). Interestingly, the cell survival 
was increased when MCF-7 were cultured without ECM 
components (lower well) and co-cultured with Matrigel or 
COL-I (upper well) (Fig. 4), suggesting that certain solu-
ble factors, such as IL-6 and IL-8 secreted from spheroid 
cells cultured in upper well, stimulated MCF-7 cells and 
promoted the cell survival in presence of anticancer 
drugs. Previously, Duan et al. [37] have reported that 
IL-6 and IL-8, known to promote cell growth and inflam-
mation, were over-expressed in taxol (paclitaxel)- and 
doxorubicin-resistant cell lines. Although both IL-6 and 
IL-8 are overexpressed in taxol (paclitaxel)-resistant 
cell lines, IL-6 has a potential to contribute directly to 
taxol (paclitaxel) resistance in human osteosarcoma. To 
elucidate whether IL-6 and IL -8 affect the cytotoxicity 
of anticancer drugs in MCF-7 cells, we measured cell 
viability after treatment with camptothecin with or without 
IL-6 and IL-8. The results are presented on Fig. 5. 
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Fig. 4. Effect of camptothecin on monolayer MCF-7 cells co-cul-
tured with MCF-7 colonies. MCF-7 cells were seeded on BSA-, 
COL-I-, and Matrigel-coated upper wells in trans-well chambers 
and then monolayer of MCF-7 cells were cultured in the lower 
chambers. 10 μM camptothecin was added to the lower chamber 
well and incubated for 72 h after the addition of camptothecin. 
Data are express as mean ± S.E.M. (*P < 0.05 vs BSA). 
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Fig. 5. Effects of Interleukin-6 and Interleukin-8 on the cytotoxi-
city of anticancer drugs. MCF-7 cells were seeded on 96-well 
plates. After 24h, 10 μM camptothecin with IL-6 (grey bar) or 
IL-8 (dark grey bar) were added to the wells and incubated for 
72 h. Cytotoxicity was measured by XTT assay. Cell survival rate 
is expressed as % of camptothecin treated cells without Interleu-
kins (open bar). Data are express as mean ± S.E.M. (*P < 0.05, 
#P < 0.05 vs non-interleukins-treated cells).
The survival rates of MCF-7 cells treated with 1 ng/mL 
IL-6 or IL-8 were 126.7 ± 1.35% and 133.8 ± 3.11%, 
respectively, when compared with non-treated cells. 
Moreover, the survival rates for MCF-7 cells treated 
with higher concentrations of IL-6 and IL-8 (10 ng/mL) 
were 145.2 ± 4.36% and 143 ± 6.55%, respectively. 
Similar results were observed for MCF-7 cells treated 
with 10 μM paclitaxel together or without IL-6 and 
IL-8 (data not shown). Therefore, our results suggest 
that IL-6 or IL-8 secreted by MCF-7 cells cultured on 
COL-I and Matrigel could contribute to the acquisition 
of resistance to paclitaxel (taxol) and camptothecin 
by MCF-7 cells. Considering our findings and already 
published data [41], we could conclude that not only 
integrin-ECM interactions, but cytokines secreted by 
spheroid cells (IL-6 and/or IL-8) may be important for 
the development of resistance to anticancer drugs by 
MCF-7 cells cultured on COL-I and Matrigel.
Obtained results provide new insight on mechanism 
of drug resistance acquired by spheroid cells exposed 
to anticancer drugs, and could facilitate further studies 
of mechanisms of drug resistance development.
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ВЛИЯНИЕ ИНТЕРЛЕЙКИНОВ НА ECM-ОПОСРЕДОВАННОЕ 
ПРИОБРЕТЕНИЕ ХИМИОРЕЗИСТЕНТНОСТИ КЛЕТКАМИ MCF-7
Цель: изучить влияние различных компонентов внеклеточного матрикса (ECM) на приобретение химиорезистентности 
к таксолу и камптотецину клетками линии карциномы молочной железы MCF-7. Методы: клетки культивировали на платах, 
покрытых бычьим сывороточным альбумином (BSA), витронектином (VN), фибронектином (FN), коллагеном I типа (COL-I) 
или матригелем, без и с добавлением таксола (паклитаксел) или камптотецина. Влияние противоопухолевых препаратов на 
рост клеток изучали с помощью XTT-теста, изменения клеточной морфологии отмечали в фазовом контрастном микроскопе. 
Иммунофлуоресцентным методом определяли экспрессию β-тубулина. Результаты: для всех клеточных линий показано 
существенное снижение выживаемости после культивирования с противоопухолевыми препаратами без компонентов ECM, в то 
время как уровень выживаемости клеток Caco-2, MCF-7 и NCI-H292 значительно возрос при культивировании с таксолом или 
камптотецином в чашках, покрытых COL-I и матригелем. Для клеток MCF-7 показано формирование и сохранение колоний при 
культивировании в чашках с COL-I и матригелем. Более того, цитотоксичность (IC50) таксола и во время колониеобразования 
клеток MCF-7 была снижена, что позволяет предположить, что морфологические изменения могут влиять на выживаемость 
клеток при культивировании с химиопрепаратом. Для клеток MCF-7, выращиваемых на чашках с COL-I и матригелем, не 
отмечали образования плотных периферических узлов микротрубочек и конденсации хроматина. Для подтверждения данного 
наблюдения проведены опыты с клетками, растущими в виде сфероидов. Показано, что цитотоксичность химиопрепаратов по 
отношению к этим клеткам снижалась и значительно повышалась при ко-культивировании с матригелем или COL-I в верхних 
камерах. Снижение выживаемости клеток под действием химиопрепаратов эффективно ингибировалось интерлейкином-6 
(IL-6) и интерлейкином-8 (IL-8). Выводы: настоящие исследования показали, что не только интегрин-ECM-взаимодействия, 
но также и другие факторы, такие как IL-6 и IL-8, секретируемые опухолевыми клетками на чашках с COL-I и матригелем, 
участвуют в приобретении химиорезистентности опухолевыми клетками MCF-7.
Ключевые слова: сферические клетки, межклеточная адгезия, MCF-7, Caco-2, ECM, химиорезистентность.
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